Baptiste Pignon

Dr. Baptiste Pignon

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Psychiatry and Clinical Neurosciences
Verified
Journal Article
Closed access
PDF file
BPBaptiste Pignon
Baptiste Pignon
RGRaphaël Gourevitch
Raphaël Gourevitch
STSarah Tebeka
Sarah Tebeka
CDCaroline Dubertret
Caroline Dubertret
HCHélène Cardot
Hélène Cardot
APAlexandra Pham‐Scottez
Alexandra Pham‐Scottez

1 June 2018 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
LCLouise Carton
Louise Carton
BPBaptiste Pignon
Baptiste Pignon
ABAlexandre Baguet
Alexandre Baguet
IBImane Benradia
Imane Benradia
JRJean-Luc Roelandt
Jean-Luc Roelandt
BRBenjamin Rolland
Benjamin Rolland

1 October 2015 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
BRBenjamin Rolland
Benjamin Rolland
JLJulien Labreuche
Julien Labreuche
ADAlain Duhamel
Alain Duhamel
SDSylvie Deheul
Sylvie Deheul
SGSophie Gautier
Sophie Gautier
OCOlivier Cottencin
Olivier Cottencin

1 March 2018 in Schizophrenia Research
Verified
Journal Article
Closed access
BPBaptiste Pignon
Baptiste Pignon
FSFranck Schürhoff
Franck Schürhoff
ASAndrei Szöke
Andrei Szöke
PGPierre A. Geoffroy
Pierre A. Geoffroy
RJRenaud Jardri
Renaud Jardri
AAAli Amad
Ali Amad

1 July 2019 in Current Psychiatry Reports
Verified
Journal Article
Closed access
PDF file
CMChloé Tezenas du Montcel
Chloé Tezenas du Montcel
APAntoine Pelissolo
Antoine Pelissolo
FSFranck Schürhoff
Franck Schürhoff
BPBaptiste Pignon
Baptiste Pignon

17 September 2020 in Psychosomatic Medicine
Verified
Journal Article
Closed access
CKCélia PharmaD Kowal
Célia PharmaD Kowal
HPHugo Peyre
Hugo Peyre
AAAli Amad
Ali Amad
APAntoine Pelissolo
Antoine Pelissolo
MLMarion Leboyer
Marion Leboyer
BPBaptiste Pignon
Baptiste Pignon
Objective: Several studies have shown that psychiatric disorders can be associated with venous thromboembolism (VTE) risk, that is, pulmonary embolism (PE) and/or deep vein thrombosis (DVT). In this study, we provide a systematic review and meta-analyses of the studies addressing this issue. Methods: All studies addressing the risk of VTE phenomena (whole VTE, PE, DVT, fatal VTE) in individuals with psychotic, mood, and anxiety disorders published between 1998 and 2019 were reviewed and included in the meta-analyses. Main characteristics of the studies and data concerning VTE risk were extracted. The methodological qualities of the studies were also analyzed. A random-effects meta-analysis model was used. A meta-analysis was conducted separately for each disorder, as well as separately for unadjusted and adjusted studies. Meta-analyses were repeated considering only good-quality studies. Heterogeneity was assessed. Results: Sixteen studies were reviewed and 15 included in the meta-analyses. Psychotic and bipolar disorders were significantly associated with VTE risk (VTE, DVT, PE, and fatal VTE for psychotic disorder: odds ratios [ORs] between 1.29 and 2.20; VTE, DVT, and PE for bipolar disorder: ORs between 1.22 and 2.14). Depression and anxiety disorders were associated with VTE risk only in adjusted analyses (DVT and PE for depression: ORs = 1.29; VTE and PE for anxiety disorders: ORs between 1.14 and 1.49). Conclusions: The risk of VTE among individuals with psychiatric disorders may be explained by hypercoagulability and stasis, with both being related to, and independent of, treatment adverse effects. VTE risk should be taken into consideration in the treatment for people with psychiatric disorders.